The aim of this call was to enable continuation of the original KAW-supported COVID-19 research program. This funding allocation is for the years 2021-2022 and amounts to 50 MSEK.
A small part of the funding is allocated to new areas (see call area 2), while mostly this call is intended for supporting continued team science, among and between the research areas established.
The research is meant to create joint resources, such as well characterized, deeply molecularly profiled samples over longitudinal follow-up that can then be utilized by the participants and the research community at large, to explore key molecular questions to prevent, detect, understand, and treat COVID-19. The supported projects are expected to make these created resources available through the COVID-19 data portal.
Proposals focusing on profiling patient materials were asked to integrate biobanking and information about access to samples used. Collaborations within and across the research areas were encouraged and also new members could ask to join the research area applications with their specific and relevant new contributions.
The ongoing research areas were welcome to send a few well-coordinated collaborative proposals each to continue and strengthen their ongoing research program and to seek new directions, such as by collaborations across the research areas. Existing PIs of the RAs could participate, and new PIs with specific new contributions could be included. Collaborations within and across the research areas were encouraged and no single PI proposals could expect to be funded. The support to team science is meant to create joint resources, such as well characterized, deeply molecularly profiled samples over longitudinal follow-up that can then be utilized (samples and /or data) by the participants and the research community at large, to ask specific follow-up questions. We expect research results, data, and methods, including code, to be released throughout the project according to the FAIR principles and as early as possible in the research process. The information sharing is arranged with the COVID-19 data portal operated by SciLifeLab Data Centre. In particular, proposals based on patient material were asked to provide information about how samples will be made available for additional molecular profiling, and the efforts taken through consent collection and ethics approval to address data- and sample sharing. Separate funding for biobanking, bioinformatics and data handling was not supported, but these components and costs were asked to be integrated into the research proposals, and such integration represented another important evaluation criterium.
SciLifeLab particularly encouraged proposals that create deep, longitudinal data and databases compatible with data mining and future data-driven research. These studies could explore for example, early steps of infection, transition to severe disease or long-covid symptoms. In these types of collaborations:
Existing PIs of the ongoing research areas, along with other PIs from anywhere in Sweden who wished to join and had relevant new contributions (that the existing research areas acknowledged and supported). Proposals with collaborations within and across research areas were encouraged. The proposers were asked to contact, as early as possible, the research area coordinator about the intention to apply by sending in: broad title of the proposal, intent (few lines), collaborators (for contacts, please see program page).
Guidance for budget 5-6 MSEK for each team science proposal (total cost for years 2021-2022). If very large-scale consortium projects were suggested across several research areas, up to 10-12 MSEK proposals could be considered.
Time period for funding: 2021-2022.
The grant only covers OH costs up to 20% and a maximum coverage of 50% for LKP (payroll overhead) on personnel costs. The researcher(s) are responsible for the necessary co-funding needed at each university/department.
Application deadline: January 15, 2021
Review: SciLifeLab Management Group (pre-screening) followed by experts in the field
Decision by SciLifeLab Board: March 10, 2021
Communication to all applicants: March 16, 2021